613 related articles for article (PubMed ID: 19347834)
1. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
2. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
4. Iron oxide nanoparticles for sustained delivery of anticancer agents.
Jain TK; Morales MA; Sahoo SK; Leslie-Pelecky DL; Labhasetwar V
Mol Pharm; 2005; 2(3):194-205. PubMed ID: 15934780
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of chemically functionalized superparamagnetic nanoparticles as delivery vectors for chemotherapeutic drugs.
Hanessian S; Grzyb JA; Cengelli F; Juillerat-Jeanneret L
Bioorg Med Chem; 2008 Mar; 16(6):2921-31. PubMed ID: 18226908
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
7. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
8. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy.
Dilnawaz F; Singh A; Mohanty C; Sahoo SK
Biomaterials; 2010 May; 31(13):3694-706. PubMed ID: 20144478
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.
Zhu A; Yuan L; Jin W; Dai S; Wang Q; Xue Z; Qin A
Acta Biomater; 2009 Jun; 5(5):1489-98. PubMed ID: 19286431
[TBL] [Abstract][Full Text] [Related]
10. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
Kim C; Kim S; Oh WK; Choi M; Jang J
Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of magnetic core@shell Fe oxide@Au nanoparticles for interfacial bioactivity and bio-separation.
Park HY; Schadt MJ; Wang L; Lim II; Njoki PN; Kim SH; Jang MY; Luo J; Zhong CJ
Langmuir; 2007 Aug; 23(17):9050-6. PubMed ID: 17629315
[TBL] [Abstract][Full Text] [Related]
12. A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation.
Moon C; Kwon YM; Lee WK; Park YJ; Chang LC; Yang VC
J Biomed Mater Res A; 2008 Jan; 84(1):238-46. PubMed ID: 17607767
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
14. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation.
Botella P; Abasolo I; Fernández Y; Muniesa C; Miranda S; Quesada M; Ruiz J; Schwartz S; Corma A
J Control Release; 2011 Dec; 156(2):246-57. PubMed ID: 21756949
[TBL] [Abstract][Full Text] [Related]
15. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.
Ge Y; Zhang Y; Xia J; Ma M; He S; Nie F; Gu N
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):294-301. PubMed ID: 19564099
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
18. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells.
Tung WL; Hu SH; Liu DM
Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic gamma-Fe2O3@SiO2 nanoparticles: a novel support for the immobilization of [VO(acac)2].
Pereira C; Pereira AM; Quaresma P; Tavares PB; Pereira E; Araújo JP; Freire C
Dalton Trans; 2010 Mar; 39(11):2842-54. PubMed ID: 20200711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
